Africa Coronary and Peripheral Stents Market Outlook (2022-2033)

The Africa coronary and peripheral stents market size is expected to reach US$ 29.7 million by 2033 from US$ 25.5 million in 2024. The market is estimated to record a CAGR of 1.7% from 2025 to 2033.

Executive Summary and Africa Coronary and Peripheral Stents Market Analysis:

The Africa coronary and peripheral stents market is in a gradual development phase, driven by an increasing burden of cardiovascular and peripheral vascular diseases across urban populations. Lifestyle transitions, rising prevalence of diabetes and hypertension, and improved diagnostic awareness are supporting the adoption of interventional procedures over open surgery. Demand is largely concentrated in countries with relatively advanced healthcare systems, where private hospitals and specialist cardiac centers lead procedural volumes. Physicians in the region tend to prefer established stent technologies with strong clinical evidence, reflecting a cautious adoption environment. However, market progress is constrained by limited access to catheterization laboratories outside major cities, uneven specialist availability, and reliance on imported stent products. Reimbursement variability between public and private sectors further shapes utilization patterns. Despite these restraints, gradual infrastructure upgrades and increasing cardiology training initiatives continue to strengthen the regional market outlook.

Africa Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.

Africa Coronary and Peripheral Stents Market Outlook

The African coronary and peripheral stents market is characterized by selective penetration, with most procedures performed in tertiary-care and private hospital settings. Coronary stents dominate overall utilization, while peripheral stents are increasingly used for complex vascular conditions associated with diabetes-related limb ischemia. A key driver for the market is the growing preference for minimally invasive endovascular interventions among clinicians and patients. Compared to surgical alternatives, stenting offers faster recovery, shorter hospital stays, and lower immediate procedural risk, making it an attractive option in resource-constrained environments. This clinical preference is reinforced by improved physician training in interventional cardiology and greater exposure to international treatment guidelines. As referral networks improve and awareness of interventional solutions increases among general practitioners, patient flow toward stent-based treatments continues to rise, supporting steady market expansion across select African healthcare hubs.

Africa Coronary and Peripheral Stents Market Country Insights

Based on country, the Africa coronary and peripheral stents market is further segmented into Nigeria, Egypt, South Africa, and Algeria. South Africa held the largest share in 2024.

South Africa dominates the African coronary and peripheral stents market due to its comparatively mature healthcare infrastructure and strong interventional cardiology presence. The country has a high concentration of well-equipped private hospitals and cardiac centers that routinely perform advanced coronary interventions. Drug-eluting coronary stents are widely adopted, while peripheral stents are gaining traction for the management of complex vascular and diabetic complications. South Africa also functions as a regional referral and training hub, drawing patients from neighboring countries seeking specialized cardiovascular care. Established distributor networks and long-term partnerships with global device manufacturers ensure consistent product availability and technical support. However, market access remains uneven between private and public sectors, with public hospitals facing capacity and funding limitations. Despite this imbalance, South Africa continues to set clinical practice benchmarks for stent usage across the African region.

Africa Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Africa Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• -Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Africa Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations